Evidence map›Paper›PMID 25796592›Full record

SynthesisJournal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology2015

Cannabinoids for the Treatment of Chronic Non-Cancer Pain: An Updated Systematic Review of Randomized Controlled Trials.

M E Lynch, Mark A Ware

3 registry-linked trialsAbstract readSystematic Review
PubMed Publisher
In one paragraph

Synthesis in Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 3 registered trials, which are not on this map. Cited by 97 papers, 9 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
97citing papers in PubMed, 9 pooled it
20.8field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03210766 completednot on this map

Nabilone and THC/CBD for the Treatment of FBSS Refractory Pain

TypeobservationalSponsorAzienda Ospedaliera Universitaria Policlinico "G. Martino"Ran2014 to 2016Enrolled20ConditionsFBSSArmsNabilone, THC/CBD
NCT03639064 phase2unknown statusnot on this mapstarted 2020, after this paper: background citation

A Phase II, Randomized, Open-label, Double-blind, Two-center Study to Evaluate the Tolerability, Safety and Dose-finding of Oil Cannabis Preparation for Pain in Parkinson's Disease

TypeinterventionalSponsorUniversity Health Network, TorontoRan2020 to 2022Enrolled15ConditionsParkinson DiseaseArmsCannabis Oil
NCT07638189 phase2not yet recruitingnot on this mapstarted 2026, after this paper: background citation

Pilot Study Using Topical Cannabidiol (CBD) to Manage Osteoarthritic Knee Pain

TypeinterventionalSponsorUniversity of TennesseeRan2026 to 2028Enrolled30ConditionsOsteoarthitisArmsCannabidiol (CBD), Castor Oil (Placebo)
3 · Its place in the literature

Who cites it

97 citing papers in PubMed, 9 syntheses or guidelines pooled it, 194 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Analgesic Effects of Cannabinoids for Chronic Non-cancer Pain: a Systematic Review and Meta-Analysis with Meta-Regression.Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology · 2020
    Pooled it
  4. Pooled it
  5. Cannabis for pain in orthopedics: a systematic review focusing on study methodologyCanadian journal of surgery. Journal canadien de chirurgie · 2019
    Pooled it
  6. Pooled it
  7. Pooled it
  8. Pooled it
  9. Cannabinoids in Pain Management and Palliative Medicine.Deutsches Arzteblatt international · 2017
    Pooled it
  10. Trial
  11. Article
  12. Review
  13. Article
  14. Review
  15. ATTITUDES AND PRACTICE PATTERNS OF CANADIAN PHYSIATRISTS REGARDING MEDICAL CANNABIS.Journal of rehabilitation medicine. Clinical communications · 2025
    Article
  16. Article
  17. Review
  18. Review
  19. Article
  20. The Effects of Nicotine and Cannabinoids on Cytokines.Current pharmaceutical design · 2024
    Review

37 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 1 country.

M E LynchDepartments of Anesthesiology, Pain Medicine and Perioperative Care, Psychiatry and Pharmacology Dalhousie University, Halifax, Nova Scotia, Canada, mary.lynch@dal.ca.
Mark A Ware
Dalhousie University · CAMcGill University · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

An updated systematic review of randomized controlled trials examining cannabinoids in the treatment of chronic non-cancer pain was conducted according to PRISMA guidelines for systematic reviews reporting on health care outcomes. Eleven trials published since our last review met inclusion criteria. The quality of the trials was excellent. Seven of the trials demonstrated a significant analgesic effect. Several trials also demonstrated improvement in secondary outcomes (e.g., sleep, muscle stiffness and spasticity). Adverse effects most frequently reported such as fatigue and dizziness were mild to moderate in severity and generally well tolerated. This review adds further support that currently available cannabinoids are safe, modestly effective analgesics that provide a reasonable therapeutic option in the management of chronic non-cancer pain.

Indexed as

Randomized Controlled Trials as TopicAnalgesicsAnimalsCannabinoidsChronic PainHumansTreatment OutcomeAnalgesicsCannabinoids

Identifiers

PMID25796592
OpenAlexW1998242083

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.